Mackenzie Financial’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295K Buy
10,526
+2,106
+25% +$59.3K ﹤0.01% 1414
2026
Q1
$240K Sell
8,420
-5,177
-38% -$177K ﹤0.01% 1338
2025
Q4
$545K Buy
13,597
+683
+5% +$25K ﹤0.01% 1204
2025
Q3
$455K Sell
12,914
-495
-4% -$17.1K ﹤0.01% 1272
2025
Q2
$439K Sell
13,409
-15,734
-54% -$511K ﹤0.01% 1274
2025
Q1
$940K Buy
29,143
+13,929
+92% +$517K ﹤0.01% 1000
2024
Q4
$465K Buy
+15,214
New +$489K ﹤0.01% 1209
2024
Q2
Sell
-11,824
Closed -$360K 1544
2024
Q1
$360K Sell
11,824
-471
-4% -$15.8K ﹤0.01% 1109
2023
Q4
$439K Buy
12,295
+1,575
+15% +$58.6K ﹤0.01% 1037
2023
Q3
$448K Hold
10,720
﹤0.01% 1023
2023
Q2
$524K Buy
+10,720
New +$494K ﹤0.01% 1007
2015
Q1
Sell
-14,100
Closed -$281K 768
2014
Q4
$281K Buy
14,100
+600
+4% +$10.3K ﹤0.01% 699
2014
Q3
$199K Buy
+13,500
New +$215K ﹤0.01% 704

Other funds holding ATRC

Mackenzie Financial's ATRC Position: Q2 2026 in Review

Mackenzie Financial increased its AtriCure (ATRC) stake by 25% in Q2 2026, buying an estimated $59.3K and bringing the position to 10,526 shares worth $295K. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

Mackenzie Financial first reported a position in ATRC in Q3 2014 and has held it in 13 quarters since. The position peaked at $940K in Q1 2025. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Mackenzie Financial held 10,526 shares of AtriCure worth $295K as of Q2 2026.
  • Mackenzie Financial bought 2,106 AtriCure shares in Q2 2026, an estimated $59.3K.
  • AtriCure made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #1414 holding.
  • Mackenzie Financial first reported a position in AtriCure in Q3 2014 and has held it in 13 quarters since.
  • Mackenzie Financial's AtriCure position peaked at $940K in Q1 2025.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.